Parent File | Name | Number | Package |
---|---|---|---|
ONCOLOGY PRIMARY(#165.5) | SUBSEQUENT COURSE OF TREATMENT | 165.51 | Oncology |
Field # | Name | Loc | Type | Details |
---|---|---|---|---|
.01 | INITIATION DATE | 0;1 | DATE |
|
.02 | HEMA TRANS/ENDOCRINE PROC | 0;18 | POINTER TO HEMATOLOGIC TRANSPLANT/ENDOCRINE PROCEDURES FILE (#167) | HEMATOLOGIC TRANSPLANT/ENDOCRINE PROCEDURES(#167)
|
.021 | HEMA TRANS/ENDOCRINE PROC DATE | 0;19 | DATE |
|
.03 | RADIATION THERAPY TO CNS | 0;10 | SET |
|
.031 | RADIATION THERAPY TO CNS DATE | 0;17 | DATE |
|
.04 | SURGERY OF PRIMARY SITE | 0;4 | NUMBER |
|
.041 | SURGERY OF PRIMARY SITE DATE | 0;11 | DATE |
|
.05 | RADIATION | 0;5 | SET |
|
.051 | RADIATION DATE | 0;12 | DATE |
|
.06 | CHEMOTHERAPY | 0;6 | SET |
|
.061 | CHEMOTHERAPY DATE | 0;13 | DATE |
|
.07 | HORMONE THERAPY | 0;7 | SET |
|
.071 | HORMONE THERAPY DATE | 0;14 | DATE |
|
.08 | IMMUNOTHERAPY | 0;8 | SET |
|
.081 | IMMUNOTHERAPY DATE | 0;15 | DATE |
|
.09 | OTHER TREATMENT | 0;9 | SET |
|
.091 | OTHER TREATMENT START DATE | 0;16 | DATE |
|
1 | RADIATION SEQUENCE | 0;2 | SET |
|
2 | PLACE | 0;3 | POINTER TO FACILITY FILE (#160.19) | FACILITY(#160.19)
|
3 | SUBSEQUENT THERAPY COMMENTS | 1;0 | WORD-PROCESSING #165.513 |
|
4 | INTERSTITIAL RADIATION | 2;1 | SET |
|
5 | IODINE 125 | 2;2 | SET |
|
6 | GOLD 198 | 2;3 | SET |
|
7 | PALLADIUM 103 | 2;4 | SET |
|
8 | IRIDIUM 192 | 2;5 | SET |
|
9 | OTHER INTERSTITIAL, NOS | 2;6 | SET |
|
10 | EXTERNAL RADIATION | 2;7 | SET |
|
11 | PROSTATE REGION ONLY | 2;8 | SET |
|
12 | PROSTATE AND PELVIC NODES | 2;9 | SET |
|
13 | PROSTATE & PELVIC PARA-AORTIC | 2;10 | SET |
|
14 | DISTANT METASTATIC SITES | 2;11 | SET |
|
15 | OTHER EXTERNAL SITES, NOS | 2;12 | SET |
|
16 | RADIATION PLANNED/GIVEN | 2;13 | SET |
|
17 | TOTAL RAD DOSE (PROSTATE) | 2;14 | SET |
|
18 | TOTAL RAD DOSE (PELVIC NODES) | 2;15 | SET |
|
19 | TOTAL RAD DOSE (PARA-AORTIC) | 2;16 | SET |
|
20 | CHEMOTHERAPY PLANNED/GIVEN | 2;17 | SET |
|
21 | ADRIAMYCIN | 2;18 | SET |
|
22 | CYTOXAN | 2;19 | SET |
|
23 | METHOTREXATE | 2;20 | SET |
|
24 | 5-FLUOROURACIL | 2;21 | SET |
|
25 | OTHER | 2;22 | SET |
|
26 | HORMONE THERAPY PLANNED/GIVEN | 2;23 | SET |
|
27 | ESTROGENS | 2;24 | SET |
|
28 | ANTIANDROGENS | 2;25 | SET |
|
29 | PROGESTATIONAL AGENTS | 2;26 | SET |
|
30 | LUTEINIZING HORMONE-RELEASING | 2;27 | SET |
|
31 | ORCHIECTOMY | 2;28 | SET |
|
32 | OTHER HORMONES | 2;29 | SET |
|
33 | RECON/RESTORE - DELAYED | 2;30 | NUMBER |
|
34 | RECON/RESTORE - DELAYED DATE | 2;31 | DATE |
|
35 | SCOPE OF LYMPH NODE SURGERY | 2;32 | SET |
|
36 | SURGICAL PROC/OTHER SITE | 2;33 | SET |
|
37 | NUMBER OF NODES REMOVED | 2;34 | NUMBER |
|
38 | SCOPE OF LN SURGERY DATE | 2;35 | DATE |
|
39 | SURGICAL PROC/OTHER SITE DATE | 2;36 | DATE |
|
40 | METS SITE RESECTED | 2;37 | SET |
|
41 | METS SITE RESECTED DATE | 2;38 | DATE |
|
42 | PALLIATIVE CARE | 2;39 | SET |
|